Cannabis and ANA
Browse the latest research linking medical marijuana / medicinal cannabis and Anandamide (ANA) (a endocannabinoid)

Anandamide (also known as N-arachidonoylethanolamine or AEA), is a fatty acid neurotransmitter derived from the non-oxidative metabolism of eicosatetraenoic acid (arachidonic acid), an essential ?-6 polyunsaturated fatty acid. [Wikipedia]
Click on a study title below to open a new tab with full article, or click on a compound to see it's full list of research.
Compounds Topics Title Date
2AG,ANA sexual health in rats via experiment Endocannabinoids Interact With the Dopaminergic System to Increase Sexual Motivation: Lessons From the Sexual Satiety Phenomenon Aug 2019
Based on these data, it could be thought that sexual motivation is diminished during the long-lasting sexual inhibitory period that characterizes sexually exhausted rats and that eCBs reverse that inhibition through the modulation of the dopaminergic system.
ANA cancer,breast cancer in vitro The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation Jun 1998
These data suggest that anandamide blocks human breast cancer cell proliferation through CB1-like receptor-mediated inhibition of endogenous prolactin action at the level of prolactin receptor.
ANA autism via review Endocannabinoid signaling in the control of social behavior May 2017
Based on translational evidence, these actions of anandamide are postulated to be important in social impairment related to (i) schizophrenia, in which tempering social anxiety might be dysfunctional, as well as in (ii) ASD, where a primary deficit may be in nucleus accumbens-regulated social reward.
ANA cancer,prostate cancer in vitro Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. Jun 2003
The potent anti-proliferative and cytotoxic effects of ANA on metastatic prostatic cancer cells might provide basis for the design of new therapeutic agents for effective treatment of recurrent and invasive prostatic cancers.
ANA metabolism via review Brain activity of anandamide: a rewarding bliss? Mar 2019
We will also discuss how modulation of anandamide levels through inhibition of enzymatic metabolic pathways could provide a basis for developing new pharmaco-therapeutic tools for the treatment of substance use disorders.